BORSI, ENRICA
 Distribuzione geografica
Continente #
AS - Asia 3.328
NA - Nord America 2.651
EU - Europa 2.039
AF - Africa 213
SA - Sud America 161
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.398
Nazione #
US - Stati Uniti d'America 2.606
VN - Vietnam 1.098
CN - Cina 805
SG - Singapore 769
IT - Italia 600
GB - Regno Unito 337
DE - Germania 239
HK - Hong Kong 201
SE - Svezia 195
IN - India 141
FR - Francia 129
NL - Olanda 123
BR - Brasile 117
KR - Corea 108
RU - Federazione Russa 98
IE - Irlanda 70
CI - Costa d'Avorio 66
FI - Finlandia 48
ZA - Sudafrica 46
JP - Giappone 37
TG - Togo 36
SC - Seychelles 33
BG - Bulgaria 26
EE - Estonia 26
CH - Svizzera 25
BD - Bangladesh 24
AT - Austria 23
PH - Filippine 23
CA - Canada 22
PL - Polonia 22
MX - Messico 20
AR - Argentina 19
UA - Ucraina 18
NG - Nigeria 17
ES - Italia 16
IR - Iran 16
TH - Thailandia 16
BE - Belgio 14
TW - Taiwan 14
ID - Indonesia 12
IQ - Iraq 12
JO - Giordania 9
CO - Colombia 7
EC - Ecuador 7
RO - Romania 7
SA - Arabia Saudita 7
TR - Turchia 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
LT - Lituania 5
UZ - Uzbekistan 5
AU - Australia 4
CY - Cipro 4
VE - Venezuela 4
CL - Cile 3
PK - Pakistan 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
GR - Grecia 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 8.398
Città #
Singapore 531
Ashburn 338
Ho Chi Minh City 313
Southend 284
Chandler 262
Hanoi 241
Hefei 218
Fairfield 204
Hong Kong 195
Bologna 161
San Jose 155
Ann Arbor 108
Seoul 104
Beijing 90
Wilmington 88
Dallas 85
Houston 84
Woodbridge 83
Seattle 78
Dublin 70
Princeton 70
Cambridge 68
Abidjan 66
Santa Clara 55
Boardman 50
Lauterbourg 50
New York 50
Los Angeles 46
Dong Ket 45
Milan 42
Haiphong 39
Lomé 36
Helsinki 34
Hyderabad 33
Munich 32
Nanjing 32
Tokyo 31
Westminster 28
Fabriano 27
Padova 26
Sofia 25
Bremen 24
Frankfurt am Main 24
Berlin 23
Amsterdam 21
Bengaluru 21
Da Nang 21
Guangzhou 20
Redondo Beach 20
Salsomaggiore Terme 20
Bern 19
Redmond 19
Biên Hòa 18
Buffalo 18
Jinan 17
Turin 17
Vienna 16
Can Tho 15
Council Bluffs 15
Warsaw 15
Abeokuta 14
Ha Long 14
Nanchang 14
Saint Petersburg 14
São Paulo 14
Brussels 13
Medford 13
Quận Bình Thạnh 13
Rome 13
Shenyang 13
Johannesburg 12
Shanghai 12
Thái Nguyên 12
Falkenstein 11
Hebei 11
Lappeenranta 11
London 11
Ninh Bình 11
Redwood City 11
Tianjin 11
Washington 11
Changsha 10
Nuremberg 10
Quận Một 10
Toronto 10
Amman 9
Chicago 9
Falls Church 9
Florence 9
Mondolfo 9
Wuhan 9
Brooklyn 8
Hải Dương 8
Paris 8
Tongling 8
Yubileyny 8
Zhengzhou 8
Bến Tre 7
Catania 7
Hangzhou 7
Totale 5.362
Nome #
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 706
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 291
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 265
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 227
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 220
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 219
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 202
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients 200
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 197
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 194
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. 192
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients 189
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 185
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 181
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 179
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 176
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 175
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 172
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 172
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 168
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 166
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 165
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 165
Cap dependent translation contributes to resistance of myeloma cells to bortezomib 162
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. 162
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 154
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 153
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 149
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 147
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 147
Analysis of mismatch repair gene mutations in Turkish HNPCC patients 146
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 144
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 143
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 143
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma 141
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma 137
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma 135
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 135
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 134
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 130
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 129
Italian cancer figures, report 2012: Cancer in children and adolescents. 120
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients]. 99
AIRTUM numbers: 200,000 young Italians live with cancer 99
null 98
[Italian cancer figures, report 2011: Survival of cancer patients in Italy]. 91
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 86
Loss of nuclear beta catenin, following chibby enforced expression, activates endoplasmic reticulum stress in cells expressing the BCR-ABL1 fusion gene of chronic myeloid leukemia 83
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 81
IMPLEMENTATION OF NEXT GENERATION SEQUENCING AS BEST TOOL FOR ROUTINE EVALUATION OF MINIMAL RESIDUAL DISEASE IN THE DAILY PRACTICE OF MULTIPLE MYELOMA PATIENTS 74
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma 69
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma 52
Totale 8.549
Categoria #
all - tutte 21.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 13 11 147
2021/2022742 32 36 41 48 65 41 20 41 42 103 121 152
2022/20231.009 80 133 43 153 79 83 30 47 144 57 81 79
2023/2024450 32 44 46 37 30 86 26 84 12 13 24 16
2024/20251.293 81 130 105 111 119 56 98 49 34 131 122 257
2025/20263.627 346 854 291 291 349 145 313 149 691 198 0 0
Totale 8.549